tazobactam has been researched along with Bleeding in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, D; Li, J; Li, S; Liu, Y; Su, N; Sun, X; Tan, J; Wang, W; Wu, G; Wu, Y; Xiong, W; Yu, C; Zhang, R; Zong, Z; Zou, K | 1 |
| Cheng, FW; Fok, TF; Hui, J; Lee, N; Leung, TF; Ng, PC; Yap, F | 1 |
2 other study(ies) available for tazobactam and Bleeding
| Article | Year |
|---|---|
Cefoperazone-sulbactam and risk of coagulation disorders or bleeding: a retrospective cohort study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Blood Coagulation Disorders; Blood Platelets; Cefoperazone; Ceftazidime; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Prothrombin Time; Sulbactam; Tazobactam; Young Adult | 2020 |
Fever, pulmonary haemorrhage, and acute renal failure in a young girl.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Child; Diagnosis, Differential; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Hemorrhage; Humans; Lung Diseases; Multiple Organ Failure; Penicillanic Acid; Piperacillin; Tazobactam; Weil Disease | 2005 |